Skip to content

Study to determine analgesic affect of erector spinae block when The patient receives an erector spinae block under ultrasound guidance before laparoscopic cholecystectomy so they dont experience pain after the surgery.

Evaluation of efficacy of ultrasound guided erector spinae block for post-operative analgesia in patients undergoing laparoscopic cholecystectomies. - EPSB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033165
Enrollment
80
Registered
2021-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Ultrasound guided erector spinae block: USG guided erector spinae block will be given at T8 level with patient in sitting/supine position, 15ml of 0.375% ropivacaine on each side. Esp b

Sponsors

Dr Ram Manohar Lohia Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE I and GRADE II patients. BMI 20-30 kg/m2

Exclusion criteria

Exclusion criteria: Patients who do not give consent for the procedure. BMI >30 kg/m2. ASA GRADE >II. Patients on anticoagulants. Contraindication to regional anaesthesia, eg local sepsis, coagulopathy, preexisting peripheral neuropathies. Severe respiratory or cardiac disorders, pregnancy. Patients with chronic pain conditions. Patients with failure of ESP block.

Design outcomes

Primary

MeasureTime frame
Time to rescue analgesia.Timepoint: Time to rescue analgesia post operatively within first 24 hours.

Secondary

MeasureTime frame
Total intraoperative fentanyl consumption Timepoint: Intraoperatively;Total tramadol or other analgesic modality consumption in first 24 hours post operatively Timepoint: in first 24 hours of surgery;VAS score at 2 hourly intervals post operatively at rest and upon coughing or mobility Timepoint: at 2 hourly intervals for first 24 hours

Countries

India

Contacts

Public ContactAshwini Gupta

DR. RMLIMS

mamtaharjaidoctor@yahoo.co.in8176007015

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026